PHARMACEUTICAL COMBINATIONS COMPRISING TEGASEROD UND OMEPRAZOLE AND THEIR USE IN TREATING GASTROINTESTINAL DISORDERS

The present invention relates to a combination of a first agent inducing either a 5-HT 4 receptor agonist or antagonist or a 5-HT 3 receptor antagonist and a co-agent and pharmaceutical compositions and formulations containing the combination. The pharmaceutical combination may be employed for the t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	WILUSZ, EDWARD, JOSEPH, JR, BILLSTEIN, STEPHAN, ANTHONY, IWICKI, MARK, THOMAS, DUMOVIC, PETER, FRANCO, NICOLA, PFANNKUCHE, HANS-JUERGEN
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a combination of a first agent inducing either a 5-HT 4 receptor agonist or antagonist or a 5-HT 3 receptor antagonist and a co-agent and pharmaceutical compositions and formulations containing the combination. The pharmaceutical combination may be employed for the treatment of altered gastrointestinal motility, sensitivity, secretion or abdominal disorders. The dosage is preferably oral. The preferred first agent is tegaserod.